LONDON, UK: Ashington Innovation plc has entered into a non-binding heads of terms agreement with Calon Cardio-Technology Limited, to acquire 100% of the outstanding shares in Calon in an all-share transaction. The acquisition is subject to the completion of the proposed reverse takeover of Cell Therapy Limited (CTL) announced on 19th August 2023 as well…